Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Pomalidomide with Low Dose Dexamethasone Is Effective Irrespective of Primary or Secondary Resistance to Lenalidomide but the IMiD-Free Interval Is Important

Meletios A Dimopoulos, Maria Roussou, Nikolaos Kanellias, Maria Gavriatopoulou, Magdalini Migkou, Ioannis Panagiotidis, Evangelos Eleutherakis-Papaiakovou, Dimitrios Ziogas, Despina Fotiou, Stavroula Giannouli, Panagiotis Tsirigotis, MD PhD, Christos Poziopoulos, Sossana Delimpasi, Despoina Mparmparoussi, Charis Matsouka, Kostas Konstantopoulos, Evangelos Terpos, Efstathios Kastritis, MD

Blood (2016) 128 (22): 3310.

https://doi.org/10.1182/blood.V128.22.3310.3310

Published: 2016

Journal Articles

Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients with AL Amyloidosis Treated with Bortezomib

Efstathios Kastritis, MD, Maria Gavriatopoulou, Maria Roussou, Despina Fotiou, Dimitrios Ziogas, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Ioannis Panagiotidis, Erasmia Psimenou, Elektra Papadopoulou, Constantinos Pamboucas, Efstathios Manios, MD, Harikleia Gakiopoulou, MD, Anna Tasidou, MD, Stavroula Giannouli, Evangelos Terpos, MD PhD, Meletios A Dimopoulos

Blood (2016) 128 (22): 4500.

https://doi.org/10.1182/blood.V128.22.4500.4500

Published: 2016

Journal Articles

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Meletios A. Dimopoulos, Maria Roussou, Maria Gavriatopoulou, Erasmia Psimenou, Dimitrios Ziogas, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Panagiotidis, Argyrios Ntalianis, Evangelos Repasos, Elektra Papadopoulou, Kimon Stamatelopoulos, Efstathios Manios, Constantinos Pamboukas, Sofoklis Kontogiannis, Evangelos Terpos, Efstathios Kastritis, MD

Blood (2016) 128 (22): 4491.

https://doi.org/10.1182/blood.V128.22.4491.4491

Published: 2016

Journal Articles

Outcomes of Newly Diagnosed Myeloma Patients Requiring Dialysis: Dialysis Independence Is Associated with Rapid Myeloma Response and Predicts for Longer Survival

Meletios A. Dimopoulos, Maria Roussou, Maria Gavriatopoulou, Despina Fotiou, Dimitrios Ziogas, Magdalini Migkou, Ioannis Panagiotidis, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Erasmia Psimenou, John N Boletis, Dimitra Bacharaki, Despoina Mparmparoussi, Charis Matsouka, Stavroula Giannouli, Evangelos Terpos, Efstathios Kastritis, MD

Blood (2016) 128 (22): 4492.

https://doi.org/10.1182/blood.V128.22.4492.4492

Published: 2016

Journal Articles

Growth Differentiation Factor-15 (GDF-15) Is a New Biomarker with Independent Prognostic Significance for Survival and Renal Outcomes in Different Cohorts of Patients with Light Chain (AL) Amyloidosis

Efstathios Kastritis, MD, Giampaolo Merlini, MD, Ioannis Papassotiriou, PhD, Paolo Milani, MD, Evangelos Terpos, Marco Basset, MD, Athanasios Akalestos, Francesca Russo, Erasmia Psimenou, Filia Apostoloakou, Maria Roussou, Maria Gavriatopoulou, Despina Fotiou, Dimitrios Ziogas, Constantinos Pamboucas, Elektra Papadopoulou, Meletios A Dimopoulos, Giovanni Palladini, MD PhD

Blood (2016) 128 (22): 648.

https://doi.org/10.1182/blood.V128.22.648.648

Published: 2016

Journal Articles

Validation of the Novel Criteria for the Definition of Symptomatic Myeloma: A Single Center Experience in 216 Patients with the Previous Diagnosis of Asymptomatic Disease

Efstathios Kastritis, MD, Evangelos Terpos, Maria Roussou, Vassilis Koutoulidis, Stavroula Giannouli, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Despoina Fotiou, Dimitrios Ziogas, Ioannis Panagiotidis, Despoina Kalapanida, Eirini Katodritou, Kostas Konstantopoulos, Lia A. Moulopoulos, Meletios A. Dimopoulos

Blood (2015) 126 (23): 4251.

https://doi.org/10.1182/blood.V126.23.4251.4251

Published: 2015

Journal Articles

Real-World Prospective Evaluation of Different Geriatric Assessment Tools in Unselected Elderly Patients with Symptomatic Myeloma

Efstathios Kastritis, MD, Evangelos Terpos, Nikolaos Kanellias, Vasiliki Babali, Spyridon Orfanopoulos, Ursula Koloventzou, Maria Gavriatopoulou, Despoina Fotiou, Dimitrios Ziogas, Eftychia Kafantari, Stavroula Giannouli, Meletios A. Dimopoulos

Blood (2015) 126 (23): 4242.

https://doi.org/10.1182/blood.V126.23.4242.4242

Published: 2015

Journal Articles

Bortezomib-Based Triplets Are Associated with a High Probability of Dialysis Independence and Rapid Renal Recovery in Newly Diagnosed Myeloma Patients with Severe Renal Failure or Those Requiring Dialysis

Meletios A. Dimopoulos, Efstathios Kastritis, MD, Maria Roussou, Erasmia Psimenou, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios Ziogas, Ioannis Panagiotidis, Despoina Fotiou, Eftychia Kafantari, Stavroula Giannouli, Sofoklis Kontogiannis, Evangelos Terpos

Blood (2015) 126 (23): 1832.

https://doi.org/10.1182/blood.V126.23.1832.1832

Published: 2015

Journal Articles

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

Efstathios Kastritis, MD, Evangelos Terpos, Maria Gavriatopoulou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Dimitrios Ziogas, Ioannis Panagiotidis, Despoina Fotiou, Dimitra Gika, Despoina Kalapanida, Eftychia Kafantari, Maria Roussou, Flora Zagouri, Stavroula Giannouli, Athanasios Zomas, Kostas Konstantopoulos, Meletios A. Dimopoulos

Blood (2015) 126 (23): 3045.

https://doi.org/10.1182/blood.V126.23.3045.3045

Published: 2015

Journal Articles

Prospective Evaluation of Blood Pressure Monitoring and Baroreceptor Reflex Sensitivity (BRS) in Patients with AL Amyloidosis: Prognostic and Pathophysiologic Implications

Efstathios Kastritis, MD, Maria Roussou, Despoina Fotiou, Dimitrios Ziogas, Maria Gavriatopoulou, Kimon Stamatelopoulos, Constantinos Pamboucas, Elektra Papadopoulou, Fotios Michas, Aikaterini Lykka, Evangelos Terpos, Meletios A. Dimopoulos, Efstathios Manios

Blood (2015) 126 (23): 3054.

https://doi.org/10.1182/blood.V126.23.3054.3054

Published: 2015

NARROW

Pomalidomide with Low Dose Dexamethasone Is Effective Irrespective of Primary or Secondary Resistance to Lenalidomide but the IMiD-Free Interval Is Important

Addition of Cyclophosphamide and Higher Doses of Dexamethasone Do Not Improve Outcomes of Patients with AL Amyloidosis Treated with Bortezomib

Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma

Outcomes of Newly Diagnosed Myeloma Patients Requiring Dialysis: Dialysis Independence Is Associated with Rapid Myeloma Response and Predicts for Longer Survival

Growth Differentiation Factor-15 (GDF-15) Is a New Biomarker with Independent Prognostic Significance for Survival and Renal Outcomes in Different Cohorts of Patients with Light Chain (AL) Amyloidosis

Validation of the Novel Criteria for the Definition of Symptomatic Myeloma: A Single Center Experience in 216 Patients with the Previous Diagnosis of Asymptomatic Disease

Real-World Prospective Evaluation of Different Geriatric Assessment Tools in Unselected Elderly Patients with Symptomatic Myeloma

Bortezomib-Based Triplets Are Associated with a High Probability of Dialysis Independence and Rapid Renal Recovery in Newly Diagnosed Myeloma Patients with Severe Renal Failure or Those Requiring Dialysis

Evaluation of the Revised International Staging System (R-ISS) in an Independent Cohort of Unselected Patients with Multiple Myeloma

Prospective Evaluation of Blood Pressure Monitoring and Baroreceptor Reflex Sensitivity (BRS) in Patients with AL Amyloidosis: Prognostic and Pathophysiologic Implications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only